Results 101 to 110 of about 10,710,575 (236)
Introduction The chemokines Stromal Cell-Derived Factor-1 alpha (SDF-1 alpha/CXCL12) and Monocyte Chemotactic Protein-1 (MCP-1/CCL2) have been implicated in breast cancer progression. We recently reported elevated systemic MCP-1 in breast cancer patients.
Dwyer, Róisín M. +6 more
core +1 more source
Zhenyu Zhang,1,2,* Zhengrui Liu,1,2,* Chao Li,1 Fukai Wang,1 Zhaokun Tian,1 Xiaoyu Liu,1 Zhiyong Yu1 1Breast Surgery Ward Three, Shandong Cancer Hospital and Institute, Jinan, 250117, People’s Republic of China; 2Shandong First Medical ...
Zhang Z +6 more
doaj
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by a poor prognosis due to the lack of effective targeted therapies.
Li-Ping Ge +8 more
doaj +1 more source
BCTB Non-Invasive Breast Cancer Samples and Images
This BCTB subcollection contains breast tissue and blood samples, and associated images, where a diagnosis of non-invasive cancer has been determined by a ...
core
Neoadjuvant dual HER2 blockade with trastuzumab and pertuzumab plus chemotherapy represents the current standard-of-care for HER2-positive breast cancer.
Xiang-Rong Wu +21 more
doaj +1 more source
Current and future therapies for triple-negative breast cancer
Triple-negative breast cancer remains an aggressive and biologically heterogeneous breast cancer subtype. Although the therapeutic landscape has expanded, durable disease control remains clinically challenging in many settings.
Zi-Xun Wang +7 more
doaj +1 more source
Prospective identification of tumorigenic breast cancer cells
M. Al-Hajj +4 more
semanticscholar +1 more source
Breast cancer is the most common malignancy among women in China, with approximately 70% of cases being hormone receptor (HR)-positive. Although current therapeutic strategies have significantly improved patient outcomes, endocrine resistance remains a ...
Clinical Cancer Research Evaluation Committee of Chinese Medical Education Association +2 more
doaj

